Blue Light Cystoscopy With Cysview® Registry
← catalyst calendarNCT02660645 · readout ≤ 865 d
Sponsored by Photocure (industry) · PHO.OL — their whole pipeline →. With Catalyst Pharmaceutical Research.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
4,400estimated
Sites
23
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Apr 2014 | not stated | When the study began enrolling |
| Primary completion | Dec 2028 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2028 | estimated | The whole study's end, after follow-up |
| First posted | 2016-01-21 | estimated | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-12-18 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Bladder Cancer
Interventions
- Drug: Hexaminolevulinate hydrochloride (HCL) — also filed as Cysview®, Hexvix®
- Device: Karl Storz D-Light C Photodynamic Diagnostic (PDD) system
Primary outcome
what the primary-completion date above is the date OFRate of detection of bladder malignancies
measured 5 years
Publications
- PMID 36435710 — reports results
- PMID 38610946 — reports results
- PMID 39284074 — reports results
- PMID 34694916 — reports results
- PMID 29203268 — reports results
- PMID 34637596 — reports results
- PMID 29859728 — reports results
- PMID 34053856 — reports results
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · PHO.OL's whole pipeline · Catalyst calendar · Every registered study · What changed